TY - JOUR JO - Journal of Contemporary Brachytherapy SN - 1689-832X VL - 7 IS - 3 PY - 2015 ID - Lewis2015 TI - Case reports High-dose-rate brachytherapy – a novel treatment approach for primary clear cell adenocarcinoma of male urethra AB - The incidence of male urethral cancer is rare with age preponderance of 50 to 60 years. The standard management approach is surgery. Here, we present a novel treatment approach for male urethral cancer. Thirty-six year old male, case of primary clear cell adenocarcinoma of urethra who refused surgery, underwent cystoscopic assisted intraluminal HDR brachytherapy. Patient received a dose of 36 Gy in 9 fractions (4 Gy per fraction) followed by a boost of 24 Gy in 6 fractions. At 11 months post treatment, disease is well controlled with no post treatment toxicity so far. Intraluminal brachytherapy seems to be an effective novel treatment for male urethral cancer. AU - Lewis, Shirley AU - Pal, Mahendra AU - Bakshi, Ganesh AU - Ghadi, Yogesh G. AU - Menon, Santosh AU - Murthy, Vedang AU - Mahantshetty, Umesh SP - 248 EP - 251 DA - 2015 DO - 10.5114/jcb.2015.52316 UR - http://dx.doi.org/10.5114/jcb.2015.52316 ER -